ANDA 88816, held by Cenci. Codeine Phosphate; Phenylephrine Hydrochloride; Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 88816 (Promethazine Vc W/ Codeine), held by Cenci, was first approved by FDA on Nov 22, 1985, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 22, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Vc W/ Codeine10MG/5ML;5MG/5ML;6.25MG/5ML ยท syrup;oral | Codeine Phosphate; Phenylephrine Hydrochloride; Promethazine Hydrochloride | Discontinued |
| Oct 23, 1996 | Supplement 7Labeling | Approved | None posted |
| May 13, 1994 | Supplement 6Labeling | Approved | None posted |
| Feb 26, 1993 | Supplement 2Labeling | Approved | None posted |
| Nov 14, 1991 | Supplement 3Labeling | Approved | None posted |
| Nov 22, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters